The MJ Companies|
Mark Bower joined the MJ team in 2009 as an employee benefits consultant within our Benefits Consulting department and brings over a decade of industry experience with him. In 2022, he was named vice president of sales + strategy. Mark and his team work to provide value and unparalleled service to our clients while helping to execute healthcare and benefit strategies in alignment with their unique company goals.
In his role, Mark specializes in maximizing employee benefits strategies to support an organization’s business goals and objectives. Through his efforts, Mark manages costs and risks, enhances employee recruitment, increases employee retention and satisfaction, creates pharmaceutical solutions, and improves communication and perception of benefits to employees.
Related Blogs
Health Care Industry Trends to Watch in 2026
The MJ CompaniesHealth care organizations enter 2026 facing numerous operational, financial and liability pressures, including labor shortages, inflation, supply chain volatility and the impact of U.S. ...
Read More
2025 Ended with Softest Market Conditions Since 2017 for all Account Sizes & Majority of Lines of Business, The Council’s P/C Market Survey Shows
The MJ CompaniesThe market appeared to move further into the soft part of the insurance market cycle in Q4 2025. Premiums across all account sizes rose ...
Read More
Miles for Miles Helps People With Intellectual and Developmental Disabilities Thrive
Britni ShroutMiles Peck loves school as much for the chance to spend time with his friends as for the classroom experience. He is bracing his ...
Read More
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
DeAnn DeckThe Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
The Hard Market Is Shifting—Here’s What That Means for YOU
Adam AdlerFor years, organizations have been told the same thing at renewal: higher costs, fewer options, and little room to negotiate. Now, that message is ...
Read More
Employer Response to Pharma Shifts
Chris AntypasVolatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More